Role of deleterious single nucleotide variants in the coding regions of TNFAIP3 for Japanese autoimmune hepatitis with cirrhosis
Takashi Higuchi(Jikei University School of Medicine), Kiyoshi Migita(Fukushima Medical University), Seigo Abiru(Nagasaki Medical Center), Fujio Makita(National Hospital Organization), Hiromasa Ohira(Fukushima Medical University), Hiroshi Yatsuhashi(Nagasaki Medical Center), Kaname Yoshizawa(Shinshu University), Atsushi Naganuma, Toshihiko Kaneyoshi(Fukuyama Cardiovascular Hospital), Atsumasa Komori, Hiroshi Furukawa(Aichi Medical University), Masaaki Shimada(Nagasaki Medical Center), Minoru Nakamura(Hokkaido University of Science), Shomi Oka(University of Tsukuba), Hironao Takahashi(Nagasaki Medical Center), Hiroshi Kouno(Nagasaki Medical Center), Satoru Hashimoto(Nagasaki Medical Center), Keisuke Ario(Nagasaki Medical Center), Haruhiro Yamashita(Nagasaki Medical Center)
Cited by 22
Related Papers
Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus
|Hepatology|1990|1.2k
<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
|New England Journal of Medicine|2018|501
Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis
|Hepatology|2006|365
Nodularin, a potent inhibitor of protein phosphatases 1 and 2A, is a new environmental carcinogen in male F344 rat liver.
|PubMed|1994|290
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272